rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Tandem Diabetes Care, Inc.

TNDM · Nasdaq

Health CareMedical DevicesNot moving yet

TNDM stood above a rising 150-day average in 22 of the last 52 weekly readings, and has been out of that trend for the last 6 weeks. It is 9.6% below that average now. Medical Devices: 29% of its 181 stocks in an uptrend (−5 points in four weeks); Health Care: 28% (−9 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 6
Industry in uptrend
29% -5 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$8,712
Officials’ trades on record
13
Institutions holding
253 (+1)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 22 of 52 weeks.

21 Apr – 20 Oct
19%29%39%Apr 26Jun 26Jul 26Sep 26Oct 26

Medical Devices: A minority of its stocks are in an uptrend and the share has been slipping. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$1.2M$0Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

13 disclosed lines: House 8, Senate 0, executive 5; 5 people.

WhoDidAmountTraded
Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA31bought$1k–$15k29 Sep 2026filed 12 Oct 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officesold$15k–$50k29 Jul 2026filed 22 Sep 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officebought$15k–$50k17 Jul 2026filed 22 Sep 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officesold$1k–$15k15 May 2026filed 1 Jul 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officesold$15k–$50k30 Mar 2026filed 14 May 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officebought$15k–$50k4 Mar 2026filed 14 May 2026
Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA31bought$1k–$15k3 Mar 2026filed 7 Apr 2026
Josh Gottheimer House: U.S. House ClerkNJ05boughtjoint$1k–$15k22 Sep 2025filed 15 Oct 2025
Josh Gottheimer House: U.S. House ClerkNJ05soldjoint$1k–$15k19 Mar 2025filed 10 Apr 2025
Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA31bought$1k–$15k4 Mar 2025filed 7 Apr 2025
Josh Gottheimer House: U.S. House ClerkNJ05boughtjoint$1k–$15k5 Aug 2024filed 11 Sep 2024
Daniel S. Goldman House: U.S. House ClerkNY10sold$1k–$15k12 Jul 2023filed 13 Aug 2023

Insiders

Buy orders, 12 months0
Sale orders, 12 months2
Buyers · sellers0 · 1
WhoDidSharesTraded
Mark David NovaraEVP & CHIEF COMMERCIAL OFFICERsold187at $23.0517 Mar 2026filed 18 Mar 2026
Mark David NovaraEVP & CHIEF COMMERCIAL OFFICERsold2at $22.815 Mar 2026filed 9 Mar 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders253+1 on the quarter
New · exited47 · 46
Reported value$1.1B

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
BlackRock, Inc.added · filed 7 Aug 202611,583,125$174.8M+892,281+8.3%
Sessa Capital IM, L.P.added · filed 14 Aug 20265,100,000$77.0M+369,243+7.8%
VANGUARD PORTFOLIO MANAGEMENT LLCadded · filed 13 Aug 20264,299,667$64.9M+306,334+7.7%
First Light Asset Management, LLCadded · filed 14 Aug 20263,383,553$51.1M+2,068,838+157.4%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 20263,096,536$46.7M+57,617+1.9%
STATE STREET CORPadded · filed 7 Aug 20262,851,646$43.0M+189,386+7.1%
JENNISON ASSOCIATES LLCadded · filed 3 Aug 20262,331,429$35.2M+672,981+40.6%
Paradice Investment Management LLCreduced · filed 5 Aug 20262,024,014$30.5M-18,411−0.9%
JACOBS LEVY EQUITY MANAGEMENT, INCadded · filed 14 Aug 20262,006,429$30.3M+482,483+31.7%
Freestone Grove Partners LPadded · filed 14 Aug 20261,866,134$28.2M+535,392+40.2%
31 Mar 2023 – 30 Jun 2026
199245291Mar 23Dec 23Dec 24Sep 25Jun 26

Everyone who traded it

Jean-Claude Kyrillos Company insiderEVP & Chief Operating Officer · last 15 Oct 20261 · 0
Gilbert Ray Cisneros, Jr. HouseCA31 · last 29 Sep 20263 · 0
Elizabeth Anne Gasser Company insiderEVP, Chief Strategy Officer · last 15 Aug 20260 · 3
John F. Sheridan Company insiderPRESIDENT & CEO · last 15 Aug 20262 · 36
Leigh Vosseller Company insiderEVP & CHIEF FINANCIAL OFFICER · last 15 Aug 20265 · 19
Rick Carpenter Company insiderEVP & Chief Technology Officer · last 15 Aug 20260 · 0
Shannon Marie Hansen Company insiderEVP & Chief Legal Officer · last 15 Aug 20261 · 0
Susan Morrison Company insiderEVP & Chief Admin. Officer · last 15 Aug 20260 · 8
Donald J. Trump Executive branchWhite House Office · last 29 Jul 20262 · 3
Christopher J. Twomey Company insiderDirector · last 21 May 20261 · 11
Dick Allen Company insiderOther · last 21 May 20266 · 9
Joao Paulo Falcao Malagueira Company insiderDirector · last 21 May 20260 · 0

Same industry

RCEL Avita MedicalLeading+108%
HTFL HeartflowLeading+59%
ATRC AtriCureLeading+52%
HAE HaemoneticsLeading+47%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Profit per saleFY 2025 · to 31 Dec 202557.7%
Operating profit marginFY 2025 · to 31 Dec 2025-64.5%
Free cash flow marginFY 2025 · to 31 Dec 2025-10.2%
Return on capital employedFY 2025 · to 31 Dec 2025-29.3%
Debt to equityFY 2025 · to 31 Dec 20252.00×
Share count trendFY 2025 · to 16 Feb 20260.1%
Cash and equivalentsFY 2025 · to 31 Dec 2025$90.6M
Free cash flowFY 2025 · to 31 Dec 2025−$29.7M

Analyst forecasts

No analyst forecasts yet.